Analysts coverage and consensus

Analyst coverage
Below are listed the sell-side analysts that cover Givaudan on a regular basis.

Baader HelveaAndreas Von Arxadd
Bank of AmericaMatthew Yatesneutral
BarclaysAlex Sloaneunderweight
Berenberg BankSamantha Darbyshirehold
BNP Paribas ExaneNicola Tangneutral
Bryan GarnierPhilippine Adambuy
CICVirginie Royere Roumageneutral
Citi Investment ResearchRanulf Orrbuy
Davy ResearchCathal Kennyneutral
Deutsche BankVirginie Boucher-Fertéhold
Goldman Sachs InternationalGeorgina Fraserbuy
JefferiesCharles Bentleyunderperform
JP MorganCeline Pannutineutral
Kepler CheuvreuxPatrick Roquasbuy
MirabaudAnja Pomrehnhold
Morgan StanleyLisa De Neveunderweight
MorningstarDiana Raduunderperform
RedburnArtem Chubarovneutral
Research PartnersEugen Pergerhold
Société GénéraleThomas Swobodahold
Stifel Europe Bank AGIsha Sharmahold
UBSCharles Edenneutral
Van Lanschot KempenEric Wilmerneutral
VontobelArben Hasanajbuy
Zürcher KantonalbankDaniel Buerkioutperform


The consensus forecasts, compiled by Givaudan, are based on emails and reports received between 14 and 26 March 2024.


The consensus forecast set out below results from regular research reports made by analysts currently covering Givaudan, as detailed in the list below. This list has been drawn up to the best of Givaudan’s knowledge but does not purport to be comprehensive of all institutions publishing financial research on Givaudan.

Any opinions, forecasts, estimates, projections or predictions regarding Givaudan’s performance made by the analysts are exclusively theirs and do not represent the opinions, forecasts, estimates, projections or predictions of Givaudan or its management. The publication of this information on this website does not imply that Givaudan endorses, or concurs with, the reports, conclusions or recommendations of the cited analysts. Givaudan disclaims any liability for the accuracy or completeness of such information and does not assume any obligation to update it even if it becomes aware of any changes.

This information is provided for ease of reference only and does not constitute an offer or solicitation to buy, hold or sell Givaudan securities.

in millions of Swiss francsFY 2023 AFY 2024 EFY 2025 E Q1 2024HY 2024 
Group sales6,915     
High 7,2747,668 1,8483,712
Average 7,0567,407 1,7783,560
Low 6,8557,230 1,7113,441
LFL Group sales growth (%)4.1%     
High 7.8%5.4% 10.0%9.1%
Average 5.6%4.7% 6.9%6.2%
Low 3.4%4.0% 4.5%4.9%
Fragrance & Beauty ( F&B) sales3,312     
High 3,4783,651 8821,757
Average 3,3903,554 8501,623
Low 3,2973,445 812850
LFL F&B sales growth (%)7.6%     
High 6.8%5.7% 11.4%8.0%
Average 5.5%4.8% 7.6%6.3%
Low 4.5%3.0% 5.0%5.0%
Taste & Wellbeing (T&W) sales3,603     
High 3,8444,029 9661,955
Average 3,6593,837 9311,795
Low 3,4613,651 899921
LFL T&W sales growth (%)1.1%%     
High 9.3%7.1% 10.0%10.0%
Average 5.5%4.6% 6.4%6.0%
Low 0.4%3.5% 3.4%4.0%
Comparable EBITDA Group1,547     
High 1,7031,817  889
Average 1,6391,745  843
Low 1,5761,683  813
Comparable EBITDA margin (%)22.4%     
High 23.7%24.1%  24.5%
Average 23.2%23.6%  23.7%
Low 22.8%22.9%  23.1%
Reported EBITDA1,473     
High 1,6611,817  864
Average 1,5861,722  817
Low 1,5261,637  784
Reported EBITDA margin (%)21.3%     
High 23.3%24.1%  24.0%
Average 22.5%23.3%  22.9%
Low 21.7%22.1%  21.7%
Net income reported 893     
High 1,0361,193  520
Average 9551,071  488
Low 882966  458
Free cash flow reported920     
High 1,0381,093  471
Average 9531,015  309
Low 814890  208
Free cash flow as a % of sales13.3%     
High 15.0%14.9%  13.4%
Average 13.5%13.7%  8.7%
Low 11.3%12.0%  5.6%
Price target   
Number of estimates20 
Latest update26-03-2024 

Note: numbers might not sum-up because of rounding.